Rheumatology Advance Access originally published online on August 16, 2007
Rheumatology 2008 47(1):3-7; doi:10.1093/rheumatology/kem202
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS |
Systemic inflammation as a risk factor for atherothrombosis
1Department of Internal Medicine; Vascular Medicine and 2Department of Internal Medicine, Clinical Immunology and Rheumatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Correspondence to: Sander I. van Leuven, Academic Medical Center, Department of Vascular Medicine, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. E-mail: s.i.vanleuven{at}amc.uva.nl
| Abstract |
|---|
Several chronic inflammatory disorders, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and chronic infections that are associated with a chronic inflammatory state, such as human immunodeficiency virus (HIV) infection, are associated with an increased incidence of cardiovascular disease (CVD). Cardiovascular mortality is a major cause of death in patients with these disorders. Direct effects and indirect sequelae of systemic inflammation promote atherothrombotic vascular disease. Pathophysiological processes promoting atherogenesis can initiate years before the diagnosis of a chronic inflammatory disease is made, and since exposure to risk factors in this pre-clinical phase is widespread, early cardiovascular protection in these patients seems warranted.
KEY WORDS: Systemic inflammation, Atherosclerosis, Thrombosis, SLE, RA
Submitted 10 April 2007;
revised version accepted 3 July 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Galarraga, F. Khan, P. Kumar, T. Pullar, and J. J. F. Belch Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis Rheumatology, November 1, 2009; 48(11): 1418 - 1423. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Dayer and E. Choy Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor Rheumatology, October 23, 2009; (2009) kep329v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Grisar, C. W. Steiner, M. Bonelli, T. Karonitsch, I. Schwarzinger, G. Weigel, G. Steiner, and J. S. Smolen Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells Rheumatology, October 1, 2008; 47(10): 1476 - 1483. [Abstract] [Full Text] [PDF] |
||||
